Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical Papanicolaou tests.
Neda A MoatamedAdriana Del BarcoSung-Eun YangYong YingSarah ZhangErika F RodriguezPublished in: Cytopathology : official journal of the British Society for Clinical Cytology (2023)
Our findings indicate that clinical information regarding whether a subject is transgender and/or is receiving testosterone therapy is crucial to avoiding Pap test overcalls.